New drug combo tested for aggressive blood cancer
NCT ID NCT03709758
Summary
This early-stage study is testing whether adding the drug venetoclax to standard chemotherapy is safe for adults newly diagnosed with acute myeloid leukemia (AML). The main goal is to find the highest dose of venetoclax that can be given safely alongside chemotherapy. Researchers will also gather early information on how well this combination might work to control the cancer.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes NO responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for ACUTE MYELOID LEUKEMIA are added.
By submitting, you agree to our Terms of use
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Locations
-
Dana Farber Cancer Institute
Boston, Massachusetts, 02215, United States
-
University of Chicago
Chicago, Illinois, 60637, United States
Conditions
Explore the condition pages connected to this study.